Ulrike Gnad-Vogt
Chief Tech/Sci/R&D Officer at CureVac SE
Ulrike Gnad-Vogt active positions
| Companies | Position | Start | End |
|---|---|---|---|
CureVac SE
 CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | Chief Tech/Sci/R&D Officer | 2010-12-31 | - |
Career history of Ulrike Gnad-Vogt
Former positions of Ulrike Gnad-Vogt
| Companies | Position | Start | End |
|---|---|---|---|
| CUREVAC N.V. | Chief Tech/Sci/R&D Officer | 2010-12-31 | 2018-12-31 |
| Corporate Officer/Principal | 2018-12-31 | - |
Training of Ulrike Gnad-Vogt
| Universität des Saarlandes | Doctorate Degree |
Statistics
International
| Germany | 4 |
Operational
| Chief Tech/Sci/R&D Officer | 2 |
| Doctorate Degree | 1 |
| Corporate Officer/Principal | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| CUREVAC N.V. | Health Technology |
| Private companies | 1 |
|---|---|
CureVac SE
CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | Health Technology |
- Stock Market
- Insiders
- Ulrike Gnad-Vogt
- Experience
